20 May 2013
Keywords: Alchemia, Audeo Oncology, Oncology assets, De-merger plan
Article | 09 July 2012
Australia-based Alchemia (ASX: ACL) says it is progressing well with preparations to demerge its oncology assets, with a proposal anticipated ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 July 2012
© 2013 thepharmaletter.com